Connect with us
New WHO guidelines say GLP-1 medicines must be paired with lifestyle changes and long-term care, stressing that the world is unprepared for the rising obesity crisis.
The Trump administration strikes a landmark deal with Eli Lilly and Novo Nordisk to slash costs of obesity drugs and expand Medicare coverage starting in 2026.
